Skip to main content

Table 4 Effects of demographic characteristics on differences in the stigma for changes in SSCP scores

From: Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial

Characteristics Educational lecture group Contact-based intervention group  
n = 56 n = 59 p
Gender
 Female −2.0 (− 7.0–1.0) −10.0 (− 21.0−− 7.0) < 0.001
 Male − 3.0 (−8.0–1.0) − 8.0 (− 14.5−− 4.0) 0.008
Age
 20–29 −3.0 (− 7.0–0.0) − 12.0 (− 21.0−− 7.0) 0.006
 30–39 − 2.0 (− 6.5–2.0) − 9.0 (− 21.0−− 3.0) 0.007
 40–49 −6.0 (− 12.0–1.5) −7.5 (− 9.3−− 4.0) 0.616
 50< −3.0 (−7.0−− 2.0) −13.0 (− 16.0−− 7.5) 0.071
Has visited a mental hospital
 positive − 3.0 (− 4.5–2.5) −8.0 (−15.5−− 4.5) 0.007
 negative −3.0 (−8.0–1.0) −9.0 (− 17.0−− 5.0) < 0.001
Experience of mental illness via a family member or close friend
 positive −1.5 (−6.5–2.3) −9.0 (−17.0−−8.0) 0.001
 negative −3.0 (−7.0–0.3) −8.5 (−16.0−−4.0) 0.003
Experience of schizophrenia via a family member or close friend
 positive 1.0 (−7.0–3.0) −8.0 (−13.0−−3.8) 0.10
 negative −3.0 (−7.0–0.5) −9.0 (−16.5−−5.0) < 0.001
Psychiatric work experience
 positive −2.0 (−6.5–0.0) −9.0 (−16.0−−4.0) 0.024
 negative −3.0 (−7.0–1.0) −9.0 (−17.8−−5.3) < 0.001
Frequency of medication counseling for schizophrenia patients
 Almost every day
 A few patients a week −3.0 (−4.0–2.0) −9.0 (−18.0–2.0) 0.26
 A few patients a month −3.5 (−7.8–1.0) −9.0 (−12.0−−4.0) 0.014
 A few patients a year −2.5 (−10.0−−0.25) −9.0 (− 21.0−−5.0) 0.035
 Nothing −3.0 (−6.0–5.0) −9.0 (−35.0−−7.0) 0.017
  1. The values in the table represent changes in the median (inter-quartile range) total SSCP score
  2. Statistical analysis was performed using the Mann-Whitney U test